Y Schlussel Selected Research

salacinol

7/2021

Reduced postprandial bone resorption and greater rise in GLP-1 in overweight and obese individuals after an α-glucosidase inhibitor: a double-blinded randomized crossover trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Y Schlussel Research Topics

Disease

2	Overweight 07/2021 - 01/2017
1	Bone Resorption 07/2021
1	Obesity 11/2012

Drug/Important Bio-Agent (IBA)

1	GlucosidasesIBA 07/2021
1	salacinolIBA 07/2021
1	OsteocalcinIBA 07/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 07/2021
1	Vitamin D FDA LinkGeneric 01/2017
1	CalciumIBA 11/2012
1	IsotopesIBA 11/2012